Microcarriers

Microcarriers

Global Microcarriers Market to Reach US$3.2 Billion by 2030

The global market for Microcarriers estimated at US$1.8 Billion in the year 2023, is expected to reach US$3.2 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2023-2030. Microcarrier Consumables, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$2.5 Billion by the end of the analysis period. Growth in the Microcarrier Equipment segment is estimated at 7.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$490.6 Million While China is Forecast to Grow at 12.1% CAGR

The Microcarriers market in the U.S. is estimated at US$490.6 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$697.6 Million by the year 2030 trailing a CAGR of 12.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.9% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.

Global Microcarriers Market - Key Trends & Drivers Summarized

What Are Microcarriers and Their Role in Biotechnology?
Microcarriers are small beads used in bioreactor systems to provide a large surface area for the growth and attachment of adherent cells. These are crucial in the production of vaccines, cell therapies, and other biologics. Microcarriers enable the scale-up of cell culture processes in a controlled environment, facilitating the mass production of therapeutics and vaccines, particularly those that require cell-based manufacturing methods. The use of microcarriers is becoming increasingly important in the context of growing demand for biologics and the rapid development of new vaccines, such as those needed during pandemic responses.

Why Are Microcarriers Increasingly Adopted in Vaccine Production?
The adoption of microcarriers is particularly prominent in the vaccine production industry due to their efficiency in expanding cell cultures and maximizing production capacities within limited spaces. As the global demand for vaccines continues to rise, the ability to rapidly produce large quantities of vaccines is more critical than ever. Microcarriers support this need by allowing for high-density cell cultures, which are essential for the production of viral vectors and recombinant proteins. Additionally, the shift towards more sophisticated cell-based vaccines, which offer higher efficacy and safety profiles, further drives the use of microcarriers in vaccine development and production.

How Is Technology Advancing Microcarrier Development?
Technological advancements are significantly enhancing microcarrier development, with innovations aimed at improving the growth and attachment efficiency of cells. New materials and coatings are being developed to enhance biocompatibility and optimize cell yield and viability. Automation and monitoring technologies are also being integrated into bioreactor systems that use microcarriers, allowing for more precise control over the conditions that affect cell growth, such as temperature, pH, and oxygen levels. These improvements not only increase the efficiency of production processes but also ensure the consistency and quality of biologically derived products.

Growth in the Microcarriers Market Is Driven by Several Factors
The growth in the Microcarriers market is driven by several factors, including the expanding biologics market, advancements in cell therapy research, and the increasing need for rapid vaccine development. The biopharmaceutical industry`s ongoing shift from traditional pharmaceuticals to more complex biologics necessitates technologies that support efficient large-scale cell culture operations. Furthermore, the rising prevalence of chronic diseases and the aging global population are increasing the demand for new treatments and therapies, supporting the growth of cell-based research and manufacturing. Regulatory support for cell-based therapies and the increasing investment in biotechnology research are also significant growth drivers, ensuring that microcarriers remain indispensable in the evolving landscape of medical research and biomanufacturing.

Select Competitors (Total 43 Featured) -

• Becton, Dickinson and Company
• Corning, Inc.
• Danaher Corporation
• Eppendorf AG
• GE Healthcare
• HiMedia Laboratories
• Lonza Group AG
• Merck KgaA
• Sartorius AG
• Thermo Fisher Scientific, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.